Literature DB >> 1967386

Urokinase plasminogen activator and prognosis in breast cancer.

M J Duffy, D Reilly, C O'Sullivan, N O'Higgins, J J Fennelly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1967386     DOI： 10.1016/0140-6736(90)90571-l

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  The role of proteolytic enzymes in cancer invasion and metastasis.

Authors:  M J Duffy
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

2.  Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.

Authors:  E A Baker; F G Bergin; D J Leaper
Journal:  Mol Pathol       Date:  2000-12

3.  Proteolysis in human breast cancer.

Authors:  E A Garbett; M W Reed; T J Stephenson; N J Brown
Journal:  Mol Pathol       Date:  2000-04

4.  Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer.

Authors:  F Jänicke; M Schmitt; L Pache; K Ulm; N Harbeck; H Höfler; H Graeff
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 5.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

6.  Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy.

Authors:  W Yu; J Kim; L Ossowski
Journal:  J Cell Biol       Date:  1997-05-05       Impact factor: 10.539

7.  Proteolysis in human breast and colorectal cancer.

Authors:  E A Garbett; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

Review 8.  uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.

Authors:  Michael J Duffy; Patricia M McGowan; Nadia Harbeck; Christoph Thomssen; Manfred Schmitt
Journal:  Breast Cancer Res       Date:  2014-08-22       Impact factor: 6.466

9.  The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.

Authors:  Y H Kook; J Adamski; A Zelent; L Ossowski
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.